A review of trisomy X (47,XXX).
Trisomy X is a sex chromosome anomaly with a variable phenotype caused by the presence of an extra X chromosome in females (47,XXX instead of 46,XX). It is the most common female chromosomal abnormality, occurring in approximately 1 in 1,000 female births. As some individuals are only mildly affected or asymptomatic, it is estimated that only 10% of individuals with trisomy X are actually diagnosed. The most common physical features include tall stature, epicanthal folds, hypotonia and clinodactyly. Seizures, renal and genitourinary abnormalities, and premature ovarian failure (POF) can also be associated findings. Children with trisomy X have higher rates of motor and speech delays, with an increased risk of cognitive deficits and learning disabilities in the school-age years. Psychological features including attention deficits, mood disorders (anxiety and depression), and other psychological disorders are also more common than in the general population. Trisomy X most commonly occurs as a result of nondisjunction during meiosis, although postzygotic nondisjunction occurs in approximately 20% of cases. The risk of trisomy X increases with advanced maternal age. The phenotype in trisomy X is hypothesized to result from overexpression of genes that escape X-inactivation, but genotype-phenotype relationships remain to be defined. Diagnosis during the prenatal period by amniocentesis or chorionic villi sampling is common. Indications for postnatal diagnoses most commonly include developmental delays or hypotonia, learning disabilities, emotional or behavioral difficulties, or POF. Differential diagnosis prior to definitive karyotype results includes fragile X, tetrasomy X, pentasomy X, and Turner syndrome mosaicism. Genetic counseling is recommended. Patients diagnosed in the prenatal period should be followed closely for developmental delays so that early intervention therapies can be implemented as needed. School-age children and adolescents benefit from a psychological evaluation with an emphasis on identifying and developing an intervention plan for problems in cognitive/academic skills, language, and/or social-emotional development. Adolescents and adult women presenting with late menarche, menstrual irregularities, or fertility problems should be evaluated for POF. Patients should be referred to support organizations to receive individual and family support. The prognosis is variable, depending on the severity of the manifestations and on the quality and timing of treatment.
Tartaglia
Nicole R
NR
Department of Pediatrics, University of Colorado Denver School of Medicine, 13123 East 16th Ave., Aurora, CO 80045, USA. tartaglia.nicole@tchden.org
Howell
Susan
S
Sutherland
Ashley
A
Wilson
Rebecca
R
Wilson
Lennie
L
D005260:Female; D005817:Genetic Counseling; D006801:Humans; D007621:Karyotyping; D011296:Prenatal Diagnosis / Q000379:methods; D012729:Sex Chromosome Aberrations; D014314:Trisomy / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology* / Q000503:physiopathology
Am J Med Genet. 1993 Mar 15;45(6):761-3
8456857
Am J Hum Genet. 1983 Jan;35(1):110-6
6218752
Genet Med. 2001 May-Jun;3(3):187-91
11388759
Ment Retard Dev Disabil Res Rev. 2000;6(2):107-16
10899803
Birth Defects Orig Artic Ser. 1979;15(1):203-41
444642
Nat Genet. 1997 May;16(1):54-63
9140395
Child Dev. 1983 Apr;54(2):369-87
6347551
Birth Defects Orig Artic Ser. 1986;22(3):23-71
3814779
Pediatr Neurol. 2006 Jul;35(1):69-74
16814091
Obstet Gynecol. 1983 Sep;62(3 Suppl):70s-73s
6410314
J Med Genet. 1978 Apr;15(2):132-5
641947
J Med Genet. 2002 Mar;39(3):217-20
11897829
J Neurol Neurosurg Psychiatry. 1999 May;66(5):628-32
10209175
EMBO Rep. 2007 Jan;8(1):34-9
17203100
J Pediatr Adolesc Gynecol. 2001 May;14(2):77-80
11479104
J Med Assoc Thai. 1992 Nov;75(11):661-5
1307391
Cytogenet Cell Genet. 1997;79(1-2):1-20
9533010
Birth Defects Orig Artic Ser. 1986;22(3):293-306
3814782
Cold Spring Harb Symp Quant Biol. 1986;51 Pt 1:213-9
3034483
Lancet. 1959 Sep 26;2(7100):423-5
14406377
Prenat Diagn. 2006 Aug;26(8):667-71
16724363
Am J Med Genet A. 2004 Feb 15;125A(1):106-7
14755478
Ann Hum Biol. 1994 Jan-Feb;21(1):57-66
8147577
Schizophr Bull. 1994;20(3):495-505
7973466
Pediatrics. 1988 Oct;82(4):619-30
2459656
Am J Med Genet. 2002 Jan 8;114(1):93-8
11840512
Dev Med Child Neurol. 1994 Jun;36(6):533-44
8005365
Pediatr Res. 1989 Jun;25(6):577-9
2740147
Birth Defects Orig Artic Ser. 1990;26(4):209-23
2090319
Birth Defects Orig Artic Ser. 1979;15(1):261-6
444644
Br J Psychiatry. 1992 Apr;160:554-7
1571760
Am J Med Genet A. 2008 Jun 15;146A(12):1509-22
18481271
Pediatr Res. 1982 May;16(5):343-6
7099753
Obstet Gynecol. 1983 Nov;62(5):667-9
6621958
Arch Dis Child. 1999 Feb;80(2):192-5
10325742
Child Dev. 1982 Oct;53(5):1182-92
7140426
Am J Med Genet. 1993 Oct 15;48(3):169-73
8291574
Curr Opin Genet Dev. 2006 Jun;16(3):323-9
16647844
Pediatr Neurol. 2008 Jun;38(6):450-3
18486832
Prenat Diagn. 2004 Mar;24(3):213-8
15057956
Pediatrics. 1989 Oct;84(4):678-82
2780130
Am J Med Genet. 1984 Jun;18(2):357-64
6465205
Fertil Steril. 2003 Oct;80(4):1052-4
14556833
Prog Clin Biol Res. 1985;200:301-9
4080741
Behav Genet. 1980 Jan;10(1):31-41
7425996
Pediatrics. 1995 Aug;96(2 Pt 1):302-8
7630689
Hum Mol Genet. 2001 Jan 1;10(1):77-83
11136717
Birth Defects Orig Artic Ser. 1990;26(4):267-72
2090325
J Clin Neurophysiol. 2004 Jul-Aug;21(4):249-53
15509914
Birth Defects Orig Artic Ser. 1990;26(4):225-8
2090320
Am J Med Genet. 1995 Oct 9;60(5):356-63
8546146
Am J Med Genet. 1992 Oct 1;44(3):365-8
1488987
Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R203-8
17911163
Hum Genet. 1993 Oct;92(4):315-24
8225310
Am J Med Genet A. 2010 May;152A(5):1206-12
20425825
Hum Reprod. 1997 Jun;12(6):1125-7
9221988
Pediatrics. 1995 Oct;96(4 Pt 1):672-82
7567329
Am J Med Genet. 2002 Jun 1;110(1):11-8
12116265
Eur J Hum Genet. 2010 Mar;18(3):265-71
19568271
Dis Nerv Syst. 1973 Feb;34(2):94-7
4706862
Pediatrics. 1983 Feb;71(2):262-7
6823432
J Pediatr Endocrinol Metab. 2003 Feb;16(2):233-5
12713263
Birth Defects Orig Artic Ser. 1990;26(4):1-44
2090314